Global_World4_HCF2020.jpg

Thank you for participating in our 2-Day Virtual Forum.

Enduring Materials will be available soon on our site.

VIRTUAL MEETING     30 JUNE - 1 JULY 2020

GLOBAL HIV CLINICAL FORUM

CORONAVIRUS UPDATE: 12 MAY 2020

The Global HIV Clinical Forum 2020: Optimizing Treatment is scheduled to take place as a virtual forum meeting on 30 June - 1 July. This forum meeting will become the 1st virtual edition of the HIV Clinical Forum series.

We are available to answer any questions or concerns that you may have about your participation at the Global HIV Clinical Forum 2020: Optimizing Treatment. For more information, please contact Mr. Jesper Niesen at jesper@vironet.com.

To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.

BACKGROUND

The Global HIV Clinical Forum 2020: Optimizing Treatment provides challenging plenary lectures followed by ample time for roundtable discussions, Q&A with all session speakers, and stimulating interaction in order to bridge the knowledge gap between experts and the HIV-treating community globally. This forum meeting is a 2-day program that will be live-streamed globally.

 

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

 

The Global HIV Clinical Forum: Optimizing Treatment was initiated in 2016 by the Program Directors: Dr. Jonathan Schapiro and Dr. Charles Boucher. The aim of the forum meeting is to provide clinical education to the junior Health Care profession by inviting international key experts to give their perspective on relevant clinical topics related to the management of PLWH.

 
 
FINAL PROGRAM

DAY 1: TUESDAY, 30 JUNE 2020

 (CEST)     

06:00 PM   

Welcome, Introductions, and Goals:

Guidance on Using Online Format and Online Needs Assessment

Jonathan Schapiro, MD - Sheba Medical Center, Israel

SESSION 1 | State-Of-The Art Lectures: Update on Clinical Trials

and Their Significance for Patient Management

Session Chair: Daniel Kuritzkes, MD, Brigham and Women's Hospital, 

Harvard Medical School, Boston, MA, USA

 

 (CEST)     

06:05 PM   

Keynote Lecture:

Update on COVID-19 in HIV Infected Patients

Daniel R. Kuritzkes, MD, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA

 (CEST)     

06:25 PM   

Clinical Update: First-Line Therapies

David Wohl, MD - UNC Hospitals/University of North Carolina, Chapel Hill, NC, USA

 (CEST)     

06:45 PM   

Clinical Update: Injectable Drug Regimens

Martin Markowitz, MD - Aaron Diamond AIDS Research Center, New York, NY, USA

 (CEST)     

07:05 PM   

Clinical Update: Highly Treatment-Experienced Patients

Michael J. Kozal, MD - Yale University School of Medicine, New Haven, CT, USA

 (CEST)     

07:25 PM   

Roundtable Discussion and Q/A With Speakers From Session 1

 (CEST)     

07:45 PM   

 

Coffee Break

SESSION 2 | Reduced Drug Regimens: Scientific Considerations

Session Chair: Sharon Walmsley, MD, FRCPC, CM - University Health Network, Toronto, ON, Canada

 (CEST)     

07:55 PM   

Implications for Resistance

Robert Shafer, MD - Stanford University Medical Center, Stanford, CA, USA

 (CEST)     

08:15 PM   

Implications for Sanctuary Sites and Drug Interactions

Marta Boffito, MD, PhD - Chelsea and Westminster Hospital, London, UK

 (CEST)     

08:35 PM   

Implications for Women's Health

Sharon Walmsley, MD, FRCPC, CM - University Health Network, Toronto, ON, Canada

 (CEST)     

08:55 PM   

Clinical Case: Reduced Drug Therapy

Mary Montgomery, MD - Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA

 (CEST)     

09:10 PM   

Roundtable Discussion and Q/A With Speakers From Session 2

 (CEST)     

09:30 PM   

 

End of Day 1

DAY 2: WEDNESDAY, 1 JULY 2020

 (CEST)     

06:00 PM   

Welcome, Introductions, and Goals:

Guidance on Using Online Format and Online Needs Assessment

Jonathan Schapiro, MD - Sheba Medical Center, Israel

  SESSION 3 | Optimizing Clinical Implementation of Long-Acting Therapies

  Session Chair: Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital, London, UK

 (CEST)     

06:05 PM   

How and When to Monitor patients on LAs?

Monica Gandhi, MD, MPH - University of California, San Francisco, CA, USA

 (CEST)     

06:25 PM   

Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies

David Back, PhD - University of Liverpool, Liverpool, UK

 (CEST)     

06:45 PM   

Introducing New Therapies in Middle-Income Countries

Pedro Cahn, MD, PhD - Fundación Huésped, Buenos Aires, Argentina

 (CEST)     

07:05 PM   

Starting Long-Acting Drugs in the COVID-19 Era

Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital, London, UK

 (CEST)     

07:25 PM   

Roundtable Discussion and Q/A With Speakers From Session 3

 (CEST)     

07:45 PM   

 

Coffee Break

  SESSION 4 | HIV Prevention and Cure

  Session Chair: Jonathan Schapiro, MD - Sheba Medical Center, Israel

 (CEST)     

07:55 PM   

Update on HIV Cure

Steven Deeks, MD - University of California, San Francisco, CA, USA

 (CEST)     

08:15 PM   

HIV Vaccines - Where Are We?

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD - Desmond Tutu HIV Foundation/

University of Cape Town, Cape Town, South Africa

 (CEST)     

08:35 PM   

Oral versus Injectable PrEP

Richard Elion, MD - Clinical Professor of Medicine, George Washington School of Medicine, DC Department of Health, Washington, DC, USA

 (CEST)     

08:55 PM   

Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents

Catia Marzolini, PharmD, PhD - University Hospital Basel/University of Liverpool, Basel,

Switzerland

 (CEST)     

09:10 PM   

Roundtable Discussion and Q/A With Speakers From Session 4

 (CEST)     

09:30 PM   

Summary and Closure of Program 

Jonathan Schapiro, MD - Sheba Medical Center, Israel

 (CEST)     

09:35 PM   

 

End of Day 2

 
ENDURING MATERIALS

HAVE A LOOK AT THE PREVIOUS MEETING'S PRESENTATIONS AND CONTENT HERE:

Access the meeting proceedings of the 

SPONSOR

 
PROGRAM CHAIRS

Charles Boucher
MD, PhD

Erasmus Medical Center,

the Netherlands

Jonathan Schapiro
MD

Sheba Medical Center,

Israel

Register now for the

Global HIV Clinical Forum 2020

Virtual Forum Meeting | 30 June - 1 July

Please note: this is a virtual forum meeting. To access this workshop, you must register online!

REGISTRATION FEES

 

In order to access this virtual forum meeting, you must register onlineRegistration to the Global HIV Clinical Forum 2020 is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.


*Healthcare practitioners are defined as professionals that provide a type of health care service to patients living with HIV. Please, contact the Conference Secretariat for more information at jesper@vironet.com if you are not sure.

 
CME ACCREDITATION

 

The Global HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

 
SPONSOR

The Global HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

ENDORSERS

 

Endorsers play a key role in this meeting's success. Members of endorsing organizations receive a 25% discount on the meeting registration fees.

 

Get in touch with the Conference Secretariat by e-mail if you would like your organization to be part of the GLOBAL HIV CLINICAL FORUM 2020: OPTIMIZING TREATMENT to Mr. Jesper Niesen at jesper@vironet.com.

 
PRACTICAL INFORMATION

Practical Information

We trust that the following information (in alphabetical order) will assist you in organizing your registration to the Global HIV Clinical Forum 2020: Optimizing Treatment.

 

Certificate of Attendance

A certificate of attendance will be sent by e-mail, provided that the post-meeting evaluation survey is completed.

 

Meeting materials

An official program and speaker's bios will be sent by e-mail one day prior to the virtual forum meeting.

 

Meeting language

The official meeting language is English.

 

Disclaimer

This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of the meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.

 

Payment and procedure of online registration

Registration is free of charge to all healthcare practitioners. You will get a confirmation of the registration within 1-5 business days. If you did not receive a confirmation, please contact the Organizing Secretariat e-mail: jesper@vironet.com.

Contact

Inquiries

For any inquiries or questions, please contact Virology Education at info@virology-education.com or call +31 (0)30 230 7147. You can also contact us by filling out the contact form.

Inna Laven

Project Manager

inna@vironet.com

Jesper Niesen

Project Coordinator

jesper@vironet.com

Contact form